Skip to content

Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer

Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer: a Randomized, Multicenter, Controlled Pilot Study (EmoVie-K2)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04556344
Acronym
EmoVie_K2
Enrollment
26
Registered
2020-09-21
Start date
2020-10-26
Completion date
2023-01-05
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Neoplasms, Thoracic Neoplasms

Keywords

Emotional Intelligence, Quality of Life, cancer survivors, psychology, supportive care

Brief summary

Emotional skills are the ability to use emotions cleverly in daily life. Good emotional skills are associated with better mental and physical health in healthy and clinical populations. However, to our knowledge, cancer patients have never benefited from an intervention aiming at increasing their emotional skills. Our goal was thus to design and test such an intervention. A prospective, multi-center, randomized controlled trial (RCT) will be conducted in esogastric and lung cancer patients after antineoplastic treatments. Forty-three patients are expected in each arm. The primary outcome is the change in emotional skills assessed using a patient-reported validated questionnaire between the start and two weeks after the end of the intervention and at 2-month follow-up. The experimental arm will have to follow three individual sessions on emotional skills (i.e. identification, understanding, expression and regulation of emotions) while the control arm will have to follow three sessions of relaxation. In each arm, the first session can be held face to face or over the phone and the last two sessions will be held over the phone. Patients have exercises to practice in between sessions.It is hypothesised that the experimental group will experience a greater increase in emotional skills than the control group.

Interventions

3 sessions of 1,5 hour each. The first session can be face to face or over the phone, the two last ones will be held over the phone.

BEHAVIORALShort free talk and relaxation

3 sessions of 1,5 hour each. The first session can be face to face or over the phone, the two last ones will be held over the phone.

Sponsors

SCALab UMR CNRS 9193
CollaboratorUNKNOWN
University Hospital, Lille
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient under surveillance after curative or palliative antineoplastic treatment (surgery and/or chemoradiotherapy and/or radiotherapy alone and/or chemotherapy alone) of esogastric or bronchopulmonary cancer, * Patients with a life expectancy estimated by their physician involved in the research to be greater than or equal to six months, * Patient with a ≥ 4 score on the Distress Scale (scale from 0 to 10), * Affiliation to a social security scheme, * Mastery of the French language, * Signing of informed consent to participate in this research.

Exclusion criteria

* Cognitive disorders or unstabilized psychiatric disorders that may impair the ability of reasoning and thinking necessary to complete the questionnaires and attend workshops * Difficulty or deficiency that prevent the patient from a good understanding of the imperatives of the research * Any situation likely to significantly affect emotional competence during the study according to the investigator's judgment (in particular, ongoing psychotherapeutic follow-up)) * Patients under judicial protection (guardianship or curators).

Design outcomes

Primary

MeasureTime frameDescription
Change in patient emotional skills from baseline to 15 days after the end of interventionBetween Baseline (T0) and 15 days after the intervention (T1)Variation in patient-reported 13-item Short Profile of Emotional Competence (S-PEC) score from baseline (T0) to 15 days after the intervention (T1)

Secondary

MeasureTime frameDescription
Difficulties in Emotional RegulationBetween T0 (baseline) and T1 (15 days after the end of the intervention) and between T1 and T2 (2 months after T1)Variation in the Difficulties in Emotional Regulation Scale (DERS 16) score between T0 and T1 and between T1 and T2.
Quality of life by FACT-GAt T0 (before the first session), at T1 (15 days after the last session) and at T2 (2 months after T1).Patients' self-reported quality of life assessed using the Functional Assessment of Cancer Therapy - General (FACT-G) questionnaire
Change in quality of life using FACT-GBetween T0 (baseline) and T1 (&5 days after the end of the intervention) and between T1 and T2 (2 months after T1)Variation in assessed quality of life (FACT-G) between T0 and T1 and between T1 and T2 based on variation in emotional competence (13-item S-PEC)
Patient emotional skills at follow upBetween T0 (start of the intervention) and T2 (2 months after T1)Variation in the emotional competence score (13-item S-PEC) between Baseline (T0) and T2 (2.5 months after the last session).
Patient adherence to exercises to do at home between sessionsBetween 2 weeks and 2 monthsThe percentage of patients who have performed the suggested exercises at home between sessions
Patient satisfactionT1 (15 days after the end of the intervention) and T2 (2 months after T1)Patient-reported satisfaction regarding the intervention using ad hoc questionnaire
Patient participation in workshopsBetween 2 weeks and 2 monthsThe percentage of patients who have attended the 3 group sessions

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026